These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32298376)

  • 1. Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
    Roy Chowdhury U; Kudgus RA; Rinkoski TA; Holman BH; Bahler CK; Hann CR; Reid JM; Dosa PI; Fautsch MP
    PLoS One; 2020; 15(4):e0231841. PubMed ID: 32298376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.
    Roy Chowdhury U; Kudgus RA; Holman BH; Rinkoski TA; Hann CR; Bahler CK; McCloud E; Appt SE; Reid JM; Dosa PI; Fautsch MP
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):251-260. PubMed ID: 33784195
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent.
    Roy Chowdhury U; Pervan-Steel CL; Sheeler R; Sookdeo HK; Rogers B; Casale R; Dosa PI; Htoo T; Wirostko BM; Fautsch MP
    J Ocul Pharmacol Ther; 2023 Jun; 39(5):332-346. PubMed ID: 37200453
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.
    Roy Chowdhury U; Rinkoski TA; Bahler CK; Millar JC; Bertrand JA; Holman BH; Sherwood JM; Overby DR; Stoltz KL; Dosa PI; Fautsch MP
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5731-5742. PubMed ID: 29114841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models.
    Roy Chowdhury U; Millar JC; Holman BH; Anderson KJ; Dosa PI; Roddy GW; Fautsch MP
    Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):15. PubMed ID: 35129587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
    Vooturi SK; Kadam RS; Kompella UB
    Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug.
    Pervan-Steel CL; Roy Chowdhury U; Sookdeo HK; Casale RA; Dosa PI; Htoo TM; Fautsch MP; Wirostko BM
    Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):26. PubMed ID: 35486069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.
    Roy Chowdhury U; Bahler CK; Holman BH; Dosa PI; Fautsch MP
    PLoS One; 2015; 10(11):e0141783. PubMed ID: 26535899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS.
    Dias C; Nashed Y; Atluri H; Mitra A
    Curr Eye Res; 2002 Oct; 25(4):243-52. PubMed ID: 12658558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits.
    Lin J; Sun J; Wang Y; Ma Y; Chen W; Zhang Z; Gui G; Lin B
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):51-6. PubMed ID: 25229266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
    Kadam RS; Jadhav G; Ogidigben M; Kompella UB
    Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations.
    Suzuki G; Kunikane E; Shigemi W; Shinno K; Kozai S; Kurata M; Kawamura A
    Curr Eye Res; 2021 Mar; 46(3):380-386. PubMed ID: 32706598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24-hour evaluation of the ocular distribution of (14)C-labeled bromfenac following topical instillation into the eyes of New Zealand White rabbits.
    Baklayan GA; Patterson HM; Song CK; Gow JA; McNamara TR
    J Ocul Pharmacol Ther; 2008 Aug; 24(4):392-8. PubMed ID: 18665811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular and systemic bioavailability of ophthalmic flurbiprofen.
    Tang-Liu DD; Liu SS; Weinkam RJ
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):611-26. PubMed ID: 6533296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
    Weiss SL; Kramer WG
    J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.